IFNB1 and multiple sclerosis: More importantly, IFN‐β treatment in a multiple sclerosis patient completely reversed subfoveal neovascularization and choroiditis emphasizing the therapeutic potential of IFN‐β for inflammatory and vascular diseases of the eye (Cirino et al,2006).